Skip to main content
Podcasts

Reviewing New COVID Vaccine Data and the Effect on Accessibility


February 03, 2021

Michael Ganio, senior director, Pharmacy Practice and Quality, American Society of Health-System PharmacistsMichael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines help address accessibility, as well as impact tracking and inventory. 

Agree or disagree with an article? Share your professional thoughts on an article you read.

Your Name
3 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Back to Top